Becton, Dickinson and Company
BDX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.
Follow BDX
Becton, Dickinson and Company (BDX) Current ratio
Becton, Dickinson and Company's current ratio at the end of the quarter to 30 June 2026 was 0.9×, down 0.2× from fiscal 2025 (1.1×). Over the past ten years it has ranged from 1.0× (fiscal 2018) to 5.6× (fiscal 2017); the current reading is higher than 27% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.1× | (4.75%) |
| FY2024 | 1.2× | (10.53%) |
| FY2023 | 1.3× | 25.35% |
| FY2022 | 1.0× | (21.86%) |
| FY2021 | 1.3× | (13.21%) |
| FY2020 | 1.5× | 30.41% |
| FY2019 | 1.2× | 14.74% |
| FY2018 | 1.0× | (81.58%) |
| FY2017 | 5.6× | 285.31% |
| FY2016 | 1.4× | 12.02% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 0.9× | (8.10%) |
| Mar 2026 | 0.9× | (10.21%) |
| Dec 2025 | 1.0× | (5.78%) |
| Sep 2025 | 1.1× | 0.97% |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| RGEN Repligen Corporation compare | 9.1× |
| ISRG Intuitive Surgical, Inc. compare | 5.0× |
| MDLN Medline Inc. compare | 4.3× |
| RMD ResMed Inc. compare | 3.1× |
| WST West Pharmaceutical Services, Inc. compare | 2.8× |
| ALC Alcon compare | 2.1× |
| BAX Baxter International Inc. compare | 1.9× |
| SOLV Solventum Corporation compare | 1.0× |
| BDX Becton, Dickinson and Company | 0.9× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on BDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement